Metraipolis › archive › dc_9952a227fca7
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40940824
- DOI
- 10.3390/cancers17172726
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:49:31.642Z
- SHA-256 of the archived text
c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e- Stable URL of this page
https://metraipolis.com/documento/dc_9952a227fca7
How to cite
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824 — Europe PMC (en), https://europepmc.org/article/MED/40940824 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9952a227fca7 (Metraipolis archive dc_9952a227fca7, sha256 c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e)
BibTeX
@misc{dc9952a227fca7,
title = {Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40940824},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9952a227fca7; sha256 c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940824. Agents can read the archived copy with the MCP tool read_document.